Cargando…
A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
BACKGROUND: Melanoma is one of the most aggressive tumors with the remarkable characteristic of resistance to traditional chemotherapy and radiotherapy. Although targeted therapy and immunotherapy benefit advanced melanoma patient treatment, BRAFi (BRAF inhibitor) resistance and the lower response r...
Autores principales: | Li, Keke, Zhao, Shuang, Long, Jing, Su, Juan, Wu, Lisha, Tao, Juan, Zhou, Jianda, Zhang, JiangLin, Chen, Xiang, Peng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993520/ https://www.ncbi.nlm.nih.gov/pubmed/32021565 http://dx.doi.org/10.1186/s12935-020-1114-5 |
Ejemplares similares
-
A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway
por: Tang, Ling, et al.
Publicado: (2020) -
Chalcone-imidazolone conjugates induce apoptosis through DNA damage pathway by affecting telomeres
por: Ramaiah, M Janaki, et al.
Publicado: (2011) -
Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels
por: Li, Jiaoduan, et al.
Publicado: (2022) -
The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma
por: Guo, Yeye, et al.
Publicado: (2021) -
Novel Functions of CD147 in the Mitochondria Exacerbates Melanoma Metastasis
por: Lu, Lixia, et al.
Publicado: (2021)